GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM4, CNR1, CNR2, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR6, HTR7, MTNR1A, MTNR1B |
11.9625 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CHRM1, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, ESR1, F10, F3, FABP3, FABP4, FLT3, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR2C, HTR7, KDR, MET, MTNR1B, POLA1, POLB, PPARA, SRC, TNKS, TNKS2, XDH |
11.5744 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.9145 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
10.328 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.1324 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD2, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PPARA, TBXAS1 |
10.1324 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, FABP3, FUT7, GBA2, HTR2B, HTR2C, PIM1, PPARA, TBXAS1, TYR, XDH |
9.50505 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
9.40766 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, ESR1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2C, MTNR1B |
8.96082 |
[BP] GO:0042493 |
response to drug
|
ABCB1, ADRA1A, AKR1B1, AXL, BCL2, CA9, CDK6, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, FABP3, HSD11B2, HTR2A, HTR2B, HTR2C, KDR, POLB, SRC |
8.92978 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AXL, BCL2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, HTR5A, IGF1R, MMP2, MMP9, POLB, PPARA, SRC, TYR |
8.92978 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, ADRA1A, AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, KDR, MMP2, MMP9, POLB, PPARA, SRC, TYR |
8.73732 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TBXAS1 |
8.73732 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CDK6, CNR1, DRD1, DRD2, DRD3, HCAR2, HTR2A, HTR2B, HTR2C, KDR, SRC, TNKS, TNKS2 |
8.54008 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM4, CNR1, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
8.38637 |
[BP] GO:0007200 |
None
|
ADRA1A, CHRM1, CHRM2, CHRM4, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C |
8.35649 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7 |
8.24407 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7 |
8.24407 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HTR5A, IGF1R, KDR, MMP2, POLB, PPARA, SRC, TYR |
8.03376 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HCAR2, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
8.00951 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TBXAS1 |
7.98171 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HCAR2, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
7.98171 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TBXAS1 |
7.69732 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM4, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
7.55083 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, HTR5A, SRC, TYR |
7.51012 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, CNR1, CNR2, DRD2 |
7.38383 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B, HTR2C, KDR, SRC |
7.11043 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, CA2, CHRM1, CHRM2, CHRM4, CNR1, CNR2, DRD1, DRD2, DRD3, ESR1, HCAR2, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7, MTNR1A, MTNR1B, SIGMAR1, SRC |
6.77994 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TBXAS1, TYR, XDH |
6.71591 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FLT3, HSD11B2, HTR5A, SRC, TYR |
6.63232 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
6.58645 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TBXAS1 |
6.55289 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.53656 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F10, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP9, MTNR1B, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
6.26546 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD2, FABP3, FABP4, FUT7, GBA2, MET, PPARA, TBXAS1 |
6.20527 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TBXAS1 |
6.13812 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F10, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP9, MTNR1B, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
6.13812 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AKR1B1, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, ESRRA, F3, FABP3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP2, MMP9, PIM1, SRC, XDH |
6.12858 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AXL, BCL2, CHRM1, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRB, F10, F3, FABP4, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR2C, HTR7, IGF1R, MET, MMP1, MMP2, MMP9, PIM1, PPARA, SRC, TNKS2, TYR |
6.00587 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, ALPL, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CDK6, CHRM1, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, HTR2A, HTR2B, HTR5A, KDR, MET, MMP2, MMP9, PIM1, POLB, PPARA, PTPRS, SIGMAR1, SRC, TNKS2, TYR |
5.95655 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, POLB, SRC |
5.94485 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP1, MMP2, MMP9, MTNR1A, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
5.82184 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTPN1, PTPRS, SRC, TBXAS1, TNKS, TNKS2, TYR, XDH |
5.80955 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, GBA2, HTR1A, TYR |
5.8032 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, AKR1B1, AXL, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, MET, MTNR1B, POLA1, POLB, SRC |
5.73945 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, AKR1B1, AXL, BCL2, CA1, CA2, CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, MMP9, MTNR1A, MTNR1B, PIM1, POLB, PPARA, PTPN1, SIGMAR1, SRC, TNKS, TNKS2 |
5.69098 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PPARA, TBXAS1 |
5.56471 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, F10, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
5.53974 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.53974 |
[BP] GO:0099536 |
None
|
CHRM1, CHRM2, CHRM4, CNR1, DRD1, DRD2, DRD3, HTR2A, HTR2C, HTR6, HTR7, MTNR1B |
5.53974 |
[BP] GO:0099537 |
None
|
CHRM1, CHRM2, CHRM4, CNR1, DRD1, DRD2, DRD3, HTR2A, HTR2C, HTR6, HTR7, MTNR1B |
5.53974 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.4875 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.4875 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AXL, BCL2, CYP1B1, DRD2, F10, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, PTPN1, SRC, XDH |
5.4875 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, DRD2, DRD3, ESR1, F3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP2, MMP9, PIM1 |
5.43002 |
[BP] GO:0050795 |
None
|
ADORA1, CNR1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
5.4212 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, HTR2A, HTR2B, HTR2C, SRC, TNKS, TNKS2 |
5.34029 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
5.30352 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, HTR1A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP1, MMP2, PIM1, POLA1, POLB, PPARA, PTPN1, PTPRS, SRC, TBXAS1, TNKS, TNKS2, TYR, XDH |
5.27281 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, AXL, BCL2, CA2, CA7, CDK6, CHRM1, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, HCAR2, HTR1A, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, MTNR1B, PPARA, PTPN1, SRC |
5.26832 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
5.26269 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP1, MMP2, MMP9, MTNR1A, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
5.18863 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.14336 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
5.14336 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7, SRC |
5.09553 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, SRC |
5.07121 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR5A, PPARA, SRC |
5.00837 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
4.99419 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, ALPL, AURKB, AXL, BCL2, CA2, CA6, CA9, CDK6, CHRM2, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, KDR, MMP2, MMP9, POLA1, POLB, PPARA, PTPN1, SRC, TYR |
4.90244 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, DRD2, DRD3, ESRRA, F10, F3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, MMP2, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
4.88334 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, DRD3, HTR1A, TYR |
4.87584 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, POLB, PPARA, PTPRS, SRC, TYR |
4.85532 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DRD3, ESR1, HTR7, MTNR1A, MTNR1B, PPARA, SRC |
4.85137 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CDK6, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, HTR5A, KDR, MMP9, PIM1, POLB, PPARA, PTPRS, SIGMAR1, SRC, TYR |
4.81742 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
4.80955 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, CNR1, DRD1, DRD2, DRD3, HCAR2, TNKS, TNKS2 |
4.78989 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR5A, IGF1R, MMP2, PPARA, SRC |
4.78944 |
[BP] GO:0007268 |
None
|
CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR2A, HTR2C, HTR6, HTR7, MTNR1B |
4.75098 |
[BP] GO:0098916 |
None
|
CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR2A, HTR2C, HTR6, HTR7, MTNR1B |
4.75098 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, DRD3, FABP3, FLT3, HCAR2, HTR2A, HTR2B, HTR2C, PPARA, SRC |
4.74225 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.74225 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.74225 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, F10, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
4.74225 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, BCL2, CDK6, CHRM1, CHRM4, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
4.73969 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3 |
4.66687 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, CA2, CA7, CNR1, CNR2, DRD1, DRD2, DRD3, HTR2A |
4.6454 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, CA2, CA7, CNR1, CNR2, DRD1, DRD2, DRD3, HTR2A |
4.6454 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM4, CNR1, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR2C, HTR6, HTR7, MTNR1B |
4.57181 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.55739 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.53851 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, SRC |
4.51831 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
4.49715 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, AKR1B1, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, HTR2A, HTR2B, HTR2C, MET, MTNR1B |
4.39697 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, BCL2, CHRM1, CHRM4, CYP1A1, ESR1, FLT3, HTR1A, MET, PIM1, POLA1, SRC, TYR |
4.35153 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, GBA2, PPARA, TBXAS1 |
4.35153 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.24106 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.24106 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, AXL, BCL2, CHRM1, CHRM2, CHRM4, CNR1, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR2C, HTR6, HTR7, MTNR1B |
4.21626 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7, SRC |
4.18247 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, CNR2, DRD1, DRD2, HTR2A |
4.13795 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, MTNR1A, PTPN1, SRC, XDH |
4.11424 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, MTNR1A, PTPN1, SRC, XDH |
4.11424 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP2, MMP9, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
4.07542 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM4, CNR1, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR2C, HTR6, HTR7, MTNR1B |
4.02428 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HCAR2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, MTNR1A, MTNR1B, PIM1, POLA1, POLB, PPARA, PTPN1, PTPRS, SIGMAR1, SRC, TBXAS1, TNKS, TNKS2, TUBB3, TYR, XDH |
4.02428 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
3.97783 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM4 |
3.87957 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B, HTR2C |
3.87957 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, SRC |
3.86076 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SIGMAR1, SRC, XDH |
3.86076 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SIGMAR1, SRC, XDH |
3.82297 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS |
3.77176 |
[BP] GO:0051952 |
None
|
ADORA1, CNR1, DRD1, DRD2, DRD3, HTR2A |
3.73484 |
[BP] GO:0045776 |
None
|
ADORA1, CNR1, DRD2, DRD3, PPARA |
3.73214 |
[BP] GO:0006811 |
None
|
ABCB1, ADRA1A, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, HTR2C, PPARA |
3.69093 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, PPARA, SRC |
3.67314 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM4 |
3.61076 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2D6, CYP3A4 |
3.61076 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.61076 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
3.60219 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, DRD3, HTR1A |
3.59712 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, ALOX15, AXL, BCL2, CA2, CA7, CHRM1, CNR1, CYP19A1, DRD1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, HTR2C, MMP9, MTNR1B, PPARA, PTPN1, SRC |
3.52373 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, MTNR1A, PPARA, PTPN1, SRC, XDH |
3.46814 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, DRD3, HSD11B2, HTR2A, HTR2B, MMP2, POLB, PPARA, SRC, TYR |
3.43682 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, ALOX15, BCL2, CDK6, CNR1, CNR2, CYP19A1, DRD1, DRD2, DRD3, ESR1, ESR2, IGF1R, MET, MMP9, PPARA, PTPN1, PTPRS, SRC, XDH |
3.43029 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, MTNR1A, PPARA, PTPN1, SRC, XDH |
3.42404 |
[BP] GO:0009820 |
alkaloid metabolic process
|
CYP1A2, CYP2D6, CYP3A4 |
3.40335 |
[BP] GO:0010511 |
None
|
HTR2A, HTR2B, HTR2C |
3.40335 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CNR1, CYP19A1, DRD2, HCAR2, HTR1A, HTR2A, HTR2C, MTNR1B |
3.3843 |
[BP] GO:2001023 |
None
|
CNR1, DRD1, DRD2, DRD3, HTR2A, MET |
3.3843 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, ALOX15, DRD2, HTR2A, HTR2B, HTR2C, KDR, SRC |
3.37562 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, HTR2B, IGF1R, KDR, MMP9, PIM1, PTPN1, SIGMAR1, SRC, XDH |
3.36665 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, ALOX15, DRD2, FLT3, HTR2A, HTR2B, HTR2C, KDR, PTPN1, SRC, XDH |
3.34295 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, CNR1, DRD2, DRD3, HTR2A, MMP9 |
3.33186 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.31651 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADORA1, BCL2, CA2, CA7, CHRM1, CNR1, DRD1, DRD2, DRD3, HTR1A, HTR2A, MMP9 |
3.31651 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, GBA2 |
3.31016 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, ALOX15, DRD2, HTR2A, HTR2B, HTR2C, KDR, PTPN1, SRC |
3.2606 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
3.24255 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.23321 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.23321 |
[BP] GO:0003014 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, DRD2, HSD11B2 |
3.2226 |
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, CNR1, DRD2, DRD3, HSD11B2, PPARA |
3.19837 |
[BP] GO:0001975 |
None
|
CNR2, DRD1, DRD2, DRD3 |
3.19337 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, F10, F3, MET, SRC, XDH |
3.19199 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, FLT3, HTR2B, HTR2C, IGF1R, KDR, MET, PIM1, POLB, PTPN1, PTPRS, SRC, TNKS, XDH |
3.18696 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, CNR1, DRD1, DRD2, HTR2A |
3.08709 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, POLB, PPARA, SRC |
3.08026 |
[BP] GO:0014059 |
None
|
CNR1, DRD2, DRD3, HTR2A |
3.07705 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, GBA2, PIM1, PPARA, TBXAS1, TYR |
3.05244 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, CNR1, CNR2, DRD1, DRD2, DRD3, FABP3, FLT3, HSD11B2, IGF1R, MMP2, PPARA, SRC, TYR |
3.00085 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
2.98657 |
[BP] GO:0035265 |
organ growth
|
ADRA1A, BCL2, CYP19A1, ESR1 |
2.97207 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
2.97207 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
2.97207 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, DRD2, ESRRB, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, PTPN1, SRC, XDH |
2.96789 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
2.95577 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.95577 |
[BP] GO:0060402 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B, HTR2C |
2.94521 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
2.94458 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, FABP3, HTR2A, HTR2B, HTR2C |
2.93998 |
[BP] GO:0045777 |
None
|
ADORA1, ADRA1A, CNR1, HSD11B2 |
2.92947 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
2.92947 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, FLT3, HTR2B, HTR2C, IGF1R, KDR, MET, PIM1, POLB, PTPN1, PTPRS, SRC, TNKS, XDH |
2.89757 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.88961 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, DRD1, DRD2, DRD3, ESR1, F3, FABP4, KDR, MET, PPARA, PTPRS |
2.88749 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
2.88707 |
[BP] GO:0042596 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
2.88263 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CNR1, CYP19A1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, HTR2C, MTNR1B, SRC |
2.86699 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, CYP3A4 |
2.86414 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
2.84408 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.8356 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTPN1, PTPRS, SRC, TBXAS1, TNKS, TNKS2, TYR, XDH |
2.82417 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, SRC |
2.81673 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET |
2.78801 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, MTNR1A, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
2.78412 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, PPARA |
2.75882 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, BCL2, CNR2, DRD1, DRD2, DRD3, ESR1, ESR2, HTR2A, IGF1R, MET, MMP9, PTPN1, PTPRS, SRC, XDH |
2.75092 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, HTR6 |
2.7445 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP3A4 |
2.74229 |
[BP] GO:0070989 |
oxidative demethylation
|
CYP1A2, CYP2D6, CYP3A4 |
2.74229 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, BCL2, CNR2, DRD1, DRD2, DRD3, ESR1, ESR2, HTR2A, IGF1R, MET, MMP9, PTPN1, PTPRS, SRC, XDH |
2.74229 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2 |
2.74229 |
[BP] GO:0007208 |
None
|
HTR2A, HTR2C |
2.73792 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.73792 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, GBA2, HTR1A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, POLB, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, TYR, XDH |
2.7283 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.71787 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, FABP3, FABP4, FUT7, GBA2, MMP1, MMP2, MMP9, SRC, XDH |
2.71653 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, CNR1, CNR2, DRD1, DRD2, DRD3, FABP3, FLT3, HSD11B2, IGF1R, MMP2, PPARA, SRC, TYR |
2.70977 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, SRC, TNKS |
2.69903 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR2B, HTR2C, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTPN1, PTPRS, SRC, TBXAS1, TNKS, TNKS2, TYR, XDH |
2.69312 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
2.68469 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, ALOX15, DRD2, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, PTPN1, SRC, XDH |
2.68454 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.68161 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, BCL2, DRD2, DRD3, ESR1, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
2.67578 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, SRC |
2.66773 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.66773 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
2.66773 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
2.66773 |
[BP] GO:0060401 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B, HTR2C |
2.66558 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, DRD2, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, PTPN1, SRC, XDH |
2.66558 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, ALOX15, AURKB, BCL2, CDC25B, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, MTNR1A, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
2.66203 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, GBA2, PIM1, PPARA, TBXAS1, TYR |
2.65844 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
2.65844 |
[BP] GO:0014075 |
None
|
CNR2, DRD1, DRD2, DRD3 |
2.6561 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
2.64879 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, AXL, BCL2, CA2, CDK6, CHRM1, CHRM2, CNR1, CYP1B1, DRD2, DRD3, ESR1, ESRRA, ESRRB, F3, HCAR2, HTR2A, HTR2B, HTR2C, KDR, MET, MMP9, PIM1, PTPRS, SRC, TNKS2, XDH |
2.62839 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.61781 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CNR1, CYP19A1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, HTR2C, MTNR1B, SRC |
2.61445 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, SRC |
2.59777 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, ESR2, F10, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP9, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
2.59145 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.59145 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.59145 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.59145 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, GBA2, PIM1, PPARA, TBXAS1, TYR |
2.59136 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
2.58444 |
[BP] GO:0007610 |
None
|
BCL2, CNR1, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR2C, MTNR1A, PPARA |
2.54312 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, HTR2C |
2.53711 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, HTR7, MTNR1A, MTNR1B, PPARA |
2.52608 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.50513 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC |
2.49606 |
[BP] GO:0051781 |
None
|
AURKB, CDC25B, DRD2, DRD3, HTR2B |
2.49122 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, CNR1, DRD2, DRD3, HCAR2, HTR2B, HTR2C, MTNR1B, SRC |
2.48745 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CNR2, CYP19A1, DRD1, DRD2, DRD3, PPARA, PTPRS |
2.48381 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.47431 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.47431 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
2.46454 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, MTNR1A, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
2.44299 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PTPN1, SRC, XDH |
2.43694 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM4 |
2.43694 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.43694 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.43694 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HCAR2, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
2.43694 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, ALOX15, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
2.43694 |
[BP] GO:0051302 |
None
|
AURKB, CDC25B, DRD2, DRD3, ESRRB, HTR2B |
2.42905 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, CHRM1, CNR1, CNR2, CYP1B1, DRD1, DRD2, DRD3, HSD11B2, HTR1A, HTR2A, HTR2B, HTR7, SRC, TYR |
2.41832 |
[BP] GO:0051209 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.41715 |
[BP] GO:0051283 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.41715 |
[BP] GO:0097366 |
None
|
CNR2, DRD1, DRD2, DRD3 |
2.41715 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, HTR2C |
2.38833 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, DRD3, HTR1A, HTR2C |
2.37761 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.36932 |
[BP] GO:0009822 |
alkaloid catabolic process
|
CYP2D6, CYP3A4 |
2.36932 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.36932 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.36932 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.36932 |
[BP] GO:0033602 |
None
|
CNR1, DRD2 |
2.36932 |
[BP] GO:0019933 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.36838 |
[BP] GO:0050433 |
None
|
CNR1, DRD2, DRD3, HTR2A |
2.35996 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA3, ADRA1A, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS, XDH |
2.3591 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, HTR2C |
2.3591 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, HTR2C |
2.31541 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.3136 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.3136 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.29889 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, HTR2C |
2.2654 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, AURKB, AXL, BCL2, CNR1, DRD2, DRD3, ESR1, IGF1R, KDR, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
2.26356 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.24697 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.24697 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, CA2, CHRM1, CNR1, DRD2, DRD3, HCAR2, HTR2B, HTR2C, MTNR1B, PTPN1, SRC |
2.24577 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, HTR2C |
2.2314 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, DRD1, DRD2, DRD3, ESR1, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MMP9, PTPN1, SRC, TNKS, XDH |
2.21327 |
[BP] GO:0007568 |
aging
|
ADRA1A, AURKB, BCL2, CNR1, CYP1A1, HTR2A, POLB |
2.211 |
[BP] GO:0050994 |
None
|
ADORA1, CNR1, HCAR2, PPARA |
2.20998 |
[BP] GO:0019935 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.19951 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
2.19191 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.19191 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.18622 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, DRD3, ESRRB, HTR2A, MTNR1A, PPARA |
2.18622 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, ALOX15, AXL, CDK6, CNR1, CNR2, CYP19A1, DRD2, PTPRS |
2.17978 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, CDK6, CNR1, CNR2, CYP19A1, DRD2, ESR1, F3, FABP4, IGF1R, MET, MMP2, PPARA, PTPN1, PTPRS, SRC, XDH |
2.17843 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, DRD1, DRD2, DRD3, HTR2B, HTR5A, KDR |
2.17843 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
BCL2, DRD1, HTR1A, HTR2C |
2.15936 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9 |
2.15871 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.13637 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.13178 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.12435 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, DRD3, ESRRB, HTR2A, MTNR1A, PPARA |
2.12435 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.12435 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.12435 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.12435 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.12435 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, AXL, BCL2, CA2, CHRM1, CYP19A1, DRD1, DRD2, DRD3, HCAR2, HTR2B, SRC |
2.11607 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, SRC |
2.11435 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, SRC |
2.11316 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, HTR2C |
2.10857 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA1A, CHRM1, CHRM2, DRD2, DRD3, HCAR2, HTR2A, HTR2C |
2.09575 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.09575 |
[BP] GO:0050995 |
None
|
ADORA1, CNR1, HCAR2 |
2.09575 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AXL, BCL2, CDC25B, CNR1, CYP19A1, CYP1A1, DRD1, ESR1, ESRRB, HSD11B2, HSD17B2, MMP2, MMP9, MTNR1A, SRC |
2.09375 |
[BP] GO:0097553 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.09375 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.08405 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.08405 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, HTR2C |
2.07527 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC |
2.07527 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C |
2.06817 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
2.05578 |
[BP] GO:0051953 |
None
|
ADORA1, CNR1, DRD2 |
2.05258 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM4 |
2.05258 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.05258 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.05258 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM4 |
2.05258 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TNKS, TNKS2 |
2.0524 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.0524 |
[BP] GO:0070988 |
demethylation
|
CYP1A1, CYP1A2, CYP2D6, CYP3A4 |
2.0524 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.02507 |
[BP] GO:0051282 |
None
|
DRD1, DRD2, HTR2A, HTR2B, HTR2C |
2.00765 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MTNR1A, PPARA, SRC, TNKS, TNKS2 |
2.0058 |
[BP] GO:0007202 |
None
|
ADRA1A, HTR2A, HTR2B |
2.00497 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.00497 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, AXL, CA4, CHRM1, CHRM2, CHRM4, CNR1, CNR2, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MTNR1A, MTNR1B, PTPRS, SIGMAR1 |
9.03092 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, DRD1, DRD2, DRD3, FLT3, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MTNR1A, MTNR1B, PTPRS, SIGMAR1 |
7.44403 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, GBA2, HCAR2, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, MTNR1A, MTNR1B, PIM1, PTPN1, PTPRS, SIGMAR1, SRC, TBXAS1, TNKS, TNKS2, TYR |
6.29054 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ADORA1, ADORA3, ADRA1A, ALOX15, AXL, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MTNR1A, MTNR1B, PTPRS, SIGMAR1, SRC |
6.15374 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, GBA2, HCAR2, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MTNR1A, MTNR1B, PTPN1, PTPRS, SIGMAR1, SRC, TBXAS1, TYR |
5.95048 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, GBA2, HCAR2, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, MTNR1A, MTNR1B, PIM1, PTPN1, PTPRS, SRC |
5.53974 |
[CC] GO:0031224 |
None
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, ALPL, AXL, CA12, CA14, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CYP3A4, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, GBA2, HCAR2, HSD11B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MTNR1A, MTNR1B, PTPRS, SIGMAR1, TBXAS1, TYR |
3.43029 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, GBA2, HSD11B1, HSD11B2, HSD17B2, SIGMAR1, TBXAS1 |
3.31651 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, F10, FLT3, GBA2, HSD11B1, HSD11B2, HSD17B2, PTPN1, SIGMAR1, TBXAS1 |
3.22015 |
[CC] GO:0098590 |
plasma membrane region
|
ABCB1, ADORA1, ADRA1A, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, DRD1, DRD2, HTR2A, MET, SIGMAR1, SRC |
3.01405 |
[CC] GO:0016021 |
None
|
ABCB1, ADORA1, ADORA3, ADRA1A, ALPL, AXL, CA12, CA14, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CYP3A4, DRD1, DRD2, DRD3, ESR1, F3, FLT3, FUT7, GBA2, HCAR2, HSD11B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MTNR1A, MTNR1B, PTPRS, SIGMAR1, TBXAS1, TYR |
2.65809 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, CA2, CDK6, CHRM1, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, HTR2A, HTR2B, HTR5A, HTR6, PTPRS, SRC, TUBB3 |
2.42504 |
[CC] GO:0043005 |
None
|
ADORA1, CA2, CHRM1, CHRM2, CNR1, CNR2, DRD2, HTR2A, HTR2B, HTR5A, PTPRS, SRC, TUBB3 |
2.33613 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, CA2, CDK6, CHRM1, CHRM2, CNR1, CNR2, DRD1, DRD2, HTR2A, HTR2B, HTR5A, HTR6, PTPRS, SRC, TUBB3 |
2.23896 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.19191 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRA1A, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, AURKB, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA7, CBR1, CDC25B, CDK6, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR2A, HTR5A, KDR, MMP2, MMP9, PIM1, POLA1, PTPN1, PTPRS, SIGMAR1, SRC, TBXAS1, TNKS, TNKS2, TYR, XDH |
2.00449 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
15.7847 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, TBXAS1, TNKS, TYR, XDH |
15.5266 |
[MF] GO:0008227 |
None
|
ADRA1A, CHRM1, CHRM2, CHRM4, DRD2, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7 |
12.7354 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HSD17B1, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTPN1, PTPRS, SRC, TBXAS1, TNKS, TNKS2, TUBB3, TYR, XDH |
11.9625 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MTNR1A, MTNR1B, PPARA, SIGMAR1 |
11.7222 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM4, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7 |
11.528 |
[MF] GO:0030594 |
None
|
CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7 |
11.1732 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, AXL, CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MTNR1A, MTNR1B, PPARA, SIGMAR1 |
10.9029 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MTNR1A, MTNR1B, PPARA, SIGMAR1 |
10.4957 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, POLB |
10.2015 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.0914 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, F10, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PTPN1, PTPRS, SRC, TBXAS1, TNKS, TNKS2, TUBB3, TYR, XDH |
9.60847 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4 |
9.60847 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MTNR1A, MTNR1B, PPARA, SIGMAR1 |
9.51223 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTPN1, TBXAS1, TNKS, TNKS2, TYR, XDH |
9.44706 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, TBXAS1, XDH |
9.40766 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MTNR1A, MTNR1B, SIGMAR1 |
9.09335 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MTNR1A, MTNR1B, SIGMAR1 |
9.09335 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
9.01001 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
8.64306 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
8.64306 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, CYP3A4 |
8.34981 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7 |
8.24407 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7 |
8.24407 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TBXAS1, TYR, XDH |
8.23979 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, TBXAS1, TYR |
8.0405 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, CHRM1, CHRM2, CHRM4, CNR1, CNR2, DRD1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7, MTNR1A, MTNR1B, SIGMAR1 |
7.70711 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CDK6, CHRM1, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, PIM1, PPARA, SIGMAR1, SRC |
7.55083 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, SRC, TBXAS1 |
6.85301 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, SRC, TBXAS1 |
6.56683 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, POLB |
6.55289 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, CYP3A4 |
6.35296 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, TBXAS1, TYR |
6.13812 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
5.95655 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PPARA, PTPN1, TNKS |
5.94937 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, HSD11B2, HSD17B1, POLA1, SRC, TBXAS1, XDH |
5.85443 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2D6, CYP3A4 |
5.61627 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
5.53077 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1 |
4.64032 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTPN1, TBXAS1, TNKS, TNKS2, TYR, XDH |
4.54506 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM4 |
3.87957 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.75905 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA |
3.50044 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.43029 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.43029 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.1318 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.08709 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.0804 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.01832 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.99715 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
2.74229 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.73792 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.73792 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.73792 |
[MF] GO:0071886 |
None
|
HTR2A, HTR2C |
2.73792 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
2.66773 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.60011 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.43885 |
[MF] GO:0008502 |
None
|
MTNR1A, MTNR1B |
2.36932 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.36932 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.36932 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM4 |
2.3136 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3 |
2.19191 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.12435 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.12435 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.12435 |
[MF] GO:0003674 |
molecular_function
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, MTNR1A, MTNR1B, PIM1, POLA1, POLB, PPARA, PTPN1, PTPRS, SIGMAR1, SRC, TBXAS1, TNKS, TNKS2, TUBB3, TYR, XDH |
2.10925 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.08405 |